278 related articles for article (PubMed ID: 10447031)
1. Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal, recommendations.
Gardner P
Clin Infect Dis; 1999 Jun; 28 Suppl 2():S131-5. PubMed ID: 10447031
[TBL] [Abstract][Full Text] [Related]
2. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
3. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
4. Pertussis in adults: epidemiology, signs, symptoms, and implications for vaccination.
Orenstein WA
Clin Infect Dis; 1999 Jun; 28 Suppl 2():S147-50. PubMed ID: 10447034
[TBL] [Abstract][Full Text] [Related]
5. Adolescent and adult pertussis: disease burden and prevention.
Edwards K; Freeman DM
Curr Opin Pediatr; 2006 Feb; 18(1):77-80. PubMed ID: 16470167
[TBL] [Abstract][Full Text] [Related]
6. Cellular and acellular pertussis vaccines in adults.
Keitel WA
Clin Infect Dis; 1999 Jun; 28 Suppl 2():S118-23. PubMed ID: 10447029
[TBL] [Abstract][Full Text] [Related]
7. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
Wilson TR
J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
[TBL] [Abstract][Full Text] [Related]
8. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.
Bechini A; Tiscione E; Boccalini S; Levi M; Bonanni P
Vaccine; 2012 Jul; 30(35):5179-90. PubMed ID: 22709953
[TBL] [Abstract][Full Text] [Related]
9. Pertussis in adolescents and adults: should we vaccinate?
Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
[TBL] [Abstract][Full Text] [Related]
10. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(1):13-5. PubMed ID: 21228763
[TBL] [Abstract][Full Text] [Related]
11. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.
Gidengil CA; Sandora TJ; Lee GM
Expert Rev Vaccines; 2008 Jul; 7(5):621-34. PubMed ID: 18564017
[TBL] [Abstract][Full Text] [Related]
12. [Pertussis vaccination with acellular vaccines. Tolerance--effectiveness--current vaccination recommendations].
Liese JG; Stojanov S; Belohradsky BH
Fortschr Med; 1997 Aug; 115(24):22-7. PubMed ID: 9410815
[TBL] [Abstract][Full Text] [Related]
13. Pertussis in adults: possible use of booster doses for control.
Hewlett EL
Tokai J Exp Clin Med; 1988; 13 Suppl():125-8. PubMed ID: 3078801
[TBL] [Abstract][Full Text] [Related]
14. Pertussis--United States, 2001-2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Dec; 54(50):1283-6. PubMed ID: 16371944
[TBL] [Abstract][Full Text] [Related]
15. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.
Sato H; Sato Y
Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030
[TBL] [Abstract][Full Text] [Related]
16. A "new age" in pertussis prevention new opportunities through adult vaccination.
Cortese MM; Baughman AL; Brown K; Srivastava P
Am J Prev Med; 2007 Mar; 32(3):177-185. PubMed ID: 17296469
[TBL] [Abstract][Full Text] [Related]
17. Pertussis--United States, 1997-2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(4):73-6. PubMed ID: 11837909
[TBL] [Abstract][Full Text] [Related]
18. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit.
Dylag AM; Shah SI
Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489
[TBL] [Abstract][Full Text] [Related]
19. Boostrix: a reduced-dose acellular pertussis vaccine for use in adolescents and adults.
Li WC; Wu TZ; Huang YC; Huang LM
Expert Rev Vaccines; 2009 Oct; 8(10):1317-27. PubMed ID: 19803753
[TBL] [Abstract][Full Text] [Related]
20. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
